Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.50
Bid: 32.00
Ask: 33.00
Change: -0.30 (-0.91%)
Spread: 1.00 (3.125%)
Open: 32.80
High: 32.50
Low: 32.20
Prev. Close: 32.80
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholdings

26 Aug 2016 07:00

RNS Number : 1903I
Mercia Technologies PLC
26 August 2016
 

For immediate release

26 August 2016

 

Mercia Technologies PLC

("Mercia" or the "Company")

 

Director/PDMR Shareholdings

 

Mercia Technologies PLC (AIM: MERC), a Midlands-based investment group, building, funding and commercialising technology businesses across the UK, announces the following transactions relating to ordinary shares of £0.00001 each in the capital of Mercia ("Ordinary Shares") by a Director, a PDMR and persons closely associated with them.

 

On 25 August 2016 Jonathan Diggines, an Executive Director of the Company, transferred a total of 401,786 Ordinary Shares (ISIN: GB00BSL71W47) at nil cost to Mrs Susan Diggines, a person closely associated with him. Following the transfer, Mr Diggines has an interest in 401,785 Ordinary Shares, equivalent to 0.19 per cent. of the Company's issued ordinary share capital and Mrs Diggines has an interest in 401,786 Ordinary Shares, equivalent to 0.19 per cent. of the Company's issued ordinary share capital.

 

Also on 25 August 2016 Julian Viggars, Head of Technology Investments and a PDMR, transferred a total of 75,000 Ordinary Shares at nil cost to Mrs Emma Viggars, a person closely associated with him. Following the transfer, Mr Viggars has an interest in 85,714 Ordinary Shares, equivalent to 0.04% per cent. of the Company's issued ordinary share capital and Mrs Viggars has an interest in 75,000 Ordinary Shares, equivalent to 0.04 per cent. of the Company's issued ordinary share capital.

 

Both transfers are permitted pursuant to the terms of the lock-in arrangements entered into by Messrs Diggines and Viggars at the time of the acquisition of Enterprise Ventures Group Limited by Mercia on 9 March 2016 and both transferees have agreed to be bound by the 18 month lock-in period contained in the Enterprise Ventures Group Limited share purchase agreement entered into at that time.

 

-Ends-

 

For further information, please contact:

Mercia Technologies PLC

Mark Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.merciatechnologies.com

 

+44 (0)330 223 1430

 

Cenkos Securities plc

Ivonne Cantu / Mark Connelly (NOMAD)

+44 (0)20 7397 8900

 

 

Buchanan

Sophie McNulty, Victoria Hayns, Stephanie Watson

www.buchanan.uk.com

+44 (0)20 7466 5000

 

About Mercia Technologies PLC

Mercia is a national investment group focused on the creation, funding and scaling of innovative businesses with high growth potential from the UK regions. Mercia employs 60 people across six offices and it has one of the largest university networks in the UK with 18 university partnerships across the Midlands, the North of England and Scotland. These partnerships provide access to high quality, regional deal flow which accounts for approximately one third of Mercia's investments.

 

Mercia's 'Complete Capital Solution' enable it to scale businesses via its third party funds (with more than £220.0million under management) and then over time Mercia identifies its 'Emerging Stars' which it can provide further capital to using its own balance sheet.

 

Mercia focuses on sourcing and scaling businesses across four sectors: Digital & Digital Entertainment; Life Sciences and Bio-sciences; Software & the Internet and; Electronics, Materials & Manufacturing/Engineering.

 

In a recent report (Source: Beauhurst, The Deal, 2015/16), Mercia was found to be the fifth most active investor in the UK and the fourth most active in technology. Since its IPO in December 2014, the Company continues to seek early stage third party investment opportunities and it has directly invested over £24.0million across its portfolio of Emerging Stars. In addition to providing its direct investments with the required capital, Mercia also supports the management teams to build towards exits that will realise incremental value for Mercia shareholders over the medium term.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBLGDIDSDBGLU
Date   Source Headline
13th Sep 20187:00 amRNSNotice of Capital Markets Day
29th Aug 20187:00 amRNSGrant of Options
16th Aug 20187:00 amRNSnDreams secures multi-million dollar contract
7th Aug 20187:00 amRNSOG wins significant multi-million pound contract
27th Jul 20189:30 amRNSPublication of Annual Report
17th Jul 20183:14 pmRNSPDMR / Director Dealings
2nd Jul 20187:00 amRNSPreliminary Results
20th Jun 20187:00 amRNSVirtTrade secures partnership with Formula 1
12th Jun 20187:00 amRNSBoard Appointment
21st May 20187:00 amRNSNotice of Preliminary Results
17th Apr 20187:00 amRNSBoard Change
26th Mar 20187:00 amRNSDeferred Consideration and Board Change
22nd Mar 20187:00 amRNSNew Direct Investment in Voxpopme
2nd Mar 20187:00 amRNSSale of Science Warehouse Limited
1st Feb 20187:00 amRNSMercia Annual Gala Dinner
22nd Dec 20177:00 amRNSBoard Appointment
18th Dec 20177:00 amRNSAmendment to Share Options
13th Dec 20177:00 amRNS£5.0million syndicated investment into Intechnica
11th Dec 20177:00 amRNS£3.8million syndicated investment into Medherant
6th Dec 20177:00 amRNSHalf Year Results
24th Nov 20177:00 amRNSImpression Technologies secures grant funding
17th Nov 20177:00 amRNSNew Direct Investment in £5.0m syndicated round
14th Nov 20177:00 amRNSLife Sciences & Biosciences sector update
1st Nov 20177:00 amRNSNew Partnership with the University of Edinburgh
31st Oct 20177:00 amRNSNotice of Results
25th Oct 20177:00 amRNSAppointment of Joint Broker
5th Oct 20177:00 amRNSFurther significant fund realisation achieved
3rd Oct 20177:00 amRNSWebsite launch
20th Sep 20177:00 amRNS£3.1million syndicated investment
18th Sep 201711:05 amRNSResult of AGM
18th Sep 20177:00 amRNSAGM statement
21st Aug 20177:00 amRNS£2.0m investment into Oxford Genetics
2nd Aug 20177:00 amRNSBoard Change
25th Jul 20177:00 amRNSGrant Options & PDMR Dealings
21st Jul 20177:00 amRNSPublication of Annual Report
13th Jul 20177:00 amRNSMercia invests additional £2.0million into nDreams
3rd Jul 20177:00 amRNSPreliminary results
21st Jun 20177:00 amRNSInvestment into Impression Tech & Sector Update
6th Jun 20177:00 amRNSFurther investment into Oxford Genetics
3rd May 20177:00 amRNSNotice of Preliminary Results
22nd Feb 20177:00 amRNSTwo major contracts for Northern Powerhouse Funds
17th Feb 201712:00 pmRNSNotification of Major Interest in Shares
16th Feb 201710:43 amRNSResult of General Meeting & Completion of Placing
31st Jan 20172:40 pmRNSPlacing of new Ordinary Shares to raise c.£40.0m
26th Jan 20177:00 amRNSNotice of Mercia Annual Gala Dinner
18th Jan 20177:00 amRNSNew Direct Investment in Faradion Limited
16th Dec 20167:00 amRNSSale of Allinea Software Limited to ARM
16th Nov 20167:00 amRNS£1m invested in nDreams as part of £2m syndication
10th Nov 20167:00 amRNSHalf Year Results
28th Oct 20167:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.